ATE363488T1 - Zusammensetzungen von stammzellfaktor (scf)- analogen und auf diese bezogene verfahren - Google Patents

Zusammensetzungen von stammzellfaktor (scf)- analogen und auf diese bezogene verfahren

Info

Publication number
ATE363488T1
ATE363488T1 AT97917841T AT97917841T ATE363488T1 AT E363488 T1 ATE363488 T1 AT E363488T1 AT 97917841 T AT97917841 T AT 97917841T AT 97917841 T AT97917841 T AT 97917841T AT E363488 T1 ATE363488 T1 AT E363488T1
Authority
AT
Austria
Prior art keywords
stem cell
cell factor
compositions
scf
analogues
Prior art date
Application number
AT97917841T
Other languages
English (en)
Inventor
Hsieng Lu
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Application granted granted Critical
Publication of ATE363488T1 publication Critical patent/ATE363488T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT97917841T 1996-04-05 1997-04-03 Zusammensetzungen von stammzellfaktor (scf)- analogen und auf diese bezogene verfahren ATE363488T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/628,428 US5885962A (en) 1996-04-05 1996-04-05 Stem cell factor analog compositions and method

Publications (1)

Publication Number Publication Date
ATE363488T1 true ATE363488T1 (de) 2007-06-15

Family

ID=24518837

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97917841T ATE363488T1 (de) 1996-04-05 1997-04-03 Zusammensetzungen von stammzellfaktor (scf)- analogen und auf diese bezogene verfahren

Country Status (17)

Country Link
US (1) US5885962A (de)
EP (1) EP0904367B1 (de)
JP (1) JP4066388B2 (de)
KR (1) KR20000004951A (de)
CN (1) CN1214734A (de)
AT (1) ATE363488T1 (de)
AU (1) AU726663B2 (de)
BR (1) BR9708578A (de)
CA (1) CA2249181C (de)
CZ (1) CZ301598A3 (de)
DE (1) DE69737766T2 (de)
ES (1) ES2286830T3 (de)
IL (1) IL126221A0 (de)
NO (1) NO984491L (de)
SK (1) SK131098A3 (de)
WO (1) WO1997038101A1 (de)
YU (1) YU41798A (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177556B1 (en) * 1994-11-04 2001-01-23 Applied Research Systems Ars Holdings N.V. Human SCF, a splice variant thereof, its pharmaceutical use
US5969105A (en) * 1996-10-25 1999-10-19 Feng; Yiqing Stem cell factor receptor agonists
US6967092B1 (en) 1996-10-25 2005-11-22 Mc Kearn John P Multi-functional chimeric hematopoietic receptor agonists
US6291661B1 (en) 1998-07-02 2001-09-18 Immunex Corporation flt3-L mutants and method of use
MXPA02000525A (es) * 1999-07-15 2005-07-01 Inst Genetics Llc Formulaciones de il-11.
DE60044945D1 (de) * 1999-12-23 2010-10-21 Univ Geneve Auf scf peptid basiertes basolaterales sortiersignal und inhibitoren dafür
AU2002362088A1 (en) * 2001-12-06 2003-06-23 Catholic University Method and composition for inducing weight loss
WO2003103608A2 (en) * 2002-06-11 2003-12-18 The Burnham Institute Neuroprotective synergy of erythropoietin and insulin-like growth factor
RU2013131825A (ru) * 2011-01-10 2015-02-20 Зе Реджентс Оф Зе Юниверсити Оф Мичиган Ингибитор фактора стволовых клеток
US20150018408A1 (en) 2013-07-10 2015-01-15 The Regents Of The University Of Michigan Therapeutic antibodies and uses thereof
US20150196622A1 (en) * 2012-08-21 2015-07-16 Ali Nayer Materials and methods for modulating glucose uptake
CN105985424B (zh) * 2015-01-30 2019-08-23 苏州方舟生物医药有限公司 一种干细胞因子功能性肽段及其应用
WO2016187820A1 (zh) * 2015-05-26 2016-12-01 中国科学院广州生物医药与健康研究院 一种人原代细胞培养基及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936694B1 (en) * 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
EP1241258A3 (de) * 1989-10-16 2003-12-10 Amgen Inc. Stamzellfaktor
JP2657113B2 (ja) * 1989-10-16 1997-09-24 アムジエン・インコーポレーテツド 幹細胞因子
AU8196891A (en) * 1990-06-25 1992-01-23 Immunex Corporation Mast cell growth factor
US20030125519A1 (en) * 1990-08-27 2003-07-03 Peter Besmer Ligand for the c-kit receptor and methods of use thereof
DE4224050A1 (de) * 1991-07-31 1993-02-04 Hoffmann La Roche Loesliche kit-liganden
US5525708A (en) * 1994-03-28 1996-06-11 Cytomed, Inc. Covalent dimer of kit ligand

Also Published As

Publication number Publication date
EP0904367B1 (de) 2007-05-30
NO984491D0 (no) 1998-09-25
AU2606497A (en) 1997-10-29
DE69737766D1 (de) 2007-07-12
IL126221A0 (en) 1999-05-09
ES2286830T3 (es) 2007-12-01
CN1214734A (zh) 1999-04-21
JP4066388B2 (ja) 2008-03-26
CA2249181A1 (en) 1997-10-16
AU726663B2 (en) 2000-11-16
SK131098A3 (en) 1999-03-12
NO984491L (no) 1998-10-05
JP2000508170A (ja) 2000-07-04
CA2249181C (en) 2009-11-17
YU41798A (sh) 1999-07-28
EP0904367A1 (de) 1999-03-31
CZ301598A3 (cs) 1999-01-13
BR9708578A (pt) 1999-08-03
KR20000004951A (ko) 2000-01-25
DE69737766T2 (de) 2007-10-11
WO1997038101A1 (en) 1997-10-16
US5885962A (en) 1999-03-23

Similar Documents

Publication Publication Date Title
ATE363488T1 (de) Zusammensetzungen von stammzellfaktor (scf)- analogen und auf diese bezogene verfahren
ATE348883T1 (de) Zusammensetzungen und verfahren mit analogen von g-csf
DE68929043T2 (de) Für androgen-rezeptor-protein kodierende dna
RU95115239A (ru) Аналог эритропоэтина
PT94732A (pt) Processo para a preparacao de composicoes contendo um polipeptido da proteina morfogenetica do tecido osseo
AU9315398A (en) Chemokine peptides, variants, derivatives and analogs. their use in methods to inhibit or augment an inflammatory response
GB9902660D0 (en) Plant gene
ATE105842T1 (de) Von thrombin abstammende polypeptid- zusammensetzungen und methoden für ihre benutzung.
NZ503235A (en) Amino-terminally truncated RANTES as chemokine antagonists
HUT58765A (en) Process for producing peptide compounds and pharmaceutical compositions containing them as active components
IE871871L (en) Cloning and expression of acidic fibroblast growth factor
DE69636052D1 (de) Mpl-liganden analoga
NO874704D0 (no) Minaktivin fremstilt ved rekombinant dna-teknikk.
Kameyama et al. Localization of a low Mr GTP-binding protein, rap1 protein, in plasma membranes and secretory granule membranes of rat parotid gland
NO910981L (no) Peptidforbindelser.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties